102 related articles for article (PubMed ID: 34367063)
21. Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease.
Russo GT; Giandalia A; Romeo EL; Marotta M; Alibrandi A; De Francesco C; Horvath KV; Asztalos B; Cucinotta D
J Endocrinol Invest; 2014 Mar; 37(3):261-8. PubMed ID: 24615362
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiological survey of chronic vascular complications of type 2 diabetic in-patients in four municipalities].
Zhang B; Xiang HD; Mao WB; Guo XH; Wang JC; Jia WP; Yu M; Li QF; Fu ZY; Cao WH; Qian RL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):452-6. PubMed ID: 12905763
[TBL] [Abstract][Full Text] [Related]
23. Macro- and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh.
Afroz A; Zhang W; Wei Loh AJ; Jie Lee DX; Billah B
Diabetes Metab Syndr; 2019; 13(5):2939-2946. PubMed ID: 31425960
[TBL] [Abstract][Full Text] [Related]
24. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
[TBL] [Abstract][Full Text] [Related]
25. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.
Kimando MW; Otieno FCF; Ogola EN; Mutai K
BMC Endocr Disord; 2017 Dec; 17(1):73. PubMed ID: 29191193
[TBL] [Abstract][Full Text] [Related]
26. Orthostatic hypotension in diabetic patients-10-year follow-up study.
Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
28. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines?
del Cañizo-Gómez FJ; Moreira-Andrés MN
Diabetes Res Clin Pract; 2004 Aug; 65(2):125-33. PubMed ID: 15223224
[TBL] [Abstract][Full Text] [Related]
30. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
[TBL] [Abstract][Full Text] [Related]
31. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes.
Kong AP; Yang X; Ko GT; So WY; Chan WB; Ma RC; Ng VW; Chow CC; Cockram CS; Tong PC; Wong V; Chan JC
Diabetes Care; 2007 Apr; 30(4):953-9. PubMed ID: 17259475
[TBL] [Abstract][Full Text] [Related]
32. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
[TBL] [Abstract][Full Text] [Related]
33. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.
J Hypertens; 1993 Mar; 11(3):319-25. PubMed ID: 8387090
[TBL] [Abstract][Full Text] [Related]
34. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study.
Smith NL; Savage PJ; Heckbert SR; Barzilay JI; Bittner VA; Kuller LH; Psaty BM
J Am Geriatr Soc; 2002 Mar; 50(3):416-23. PubMed ID: 11943034
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus.
Agrawal RP; Ola V; Bishnoi P; Gothwal S; Sirohi P; Agrawal R
J Assoc Physicians India; 2014 Jun; 62(6):504-8. PubMed ID: 25856915
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular complications in diabetes mellitus.
Sobel BE; Schneider DJ
Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
[TBL] [Abstract][Full Text] [Related]
37. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
38. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of degenerative complications of diabetes in an outpatient population].
Idriss-Kanoun S; Kanoun F; Hsaïri H; Machgoul M; Bahri M; Ben Khalifa F
Tunis Med; 2002 Jul; 80(7):380-6. PubMed ID: 12611347
[TBL] [Abstract][Full Text] [Related]
40. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
